71 related articles for article (PubMed ID: 19254802)
1. Activation of the lytic program of the Epstein-Barr virus in Burkitt's lymphoma cells leads to a two steps downregulation of expression of the proapoptotic protein BimEL, one of which is EBV-late-gene expression dependent.
Oussaief L; Hippocrate A; Clybouw C; Rampanou A; Ramirez V; Desgranges C; Vazquez A; Khelifa R; Joab I
Virology; 2009 Apr; 387(1):41-9. PubMed ID: 19254802
[TBL] [Abstract][Full Text] [Related]
2. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
3. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
4. EBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosis.
Clybouw C; McHichi B; Mouhamad S; Auffredou MT; Bourgeade MF; Sharma S; Leca G; Vazquez A
J Immunol; 2005 Sep; 175(5):2968-73. PubMed ID: 16116183
[TBL] [Abstract][Full Text] [Related]
5. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.
Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK
Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625
[TBL] [Abstract][Full Text] [Related]
6. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.
Inman GJ; Binné UK; Parker GA; Farrell PJ; Allday MJ
J Virol; 2001 Mar; 75(5):2400-10. PubMed ID: 11160743
[TBL] [Abstract][Full Text] [Related]
7. Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein-Barr virus in the Burkitt's lymphoma cell line, P3HR-1.
Mori T; Sairenji T
Virus Genes; 2006 Jun; 32(3):327-34. PubMed ID: 16732486
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
9. Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.
Leao M; Anderton E; Wade M; Meekings K; Allday MJ
J Virol; 2007 Jan; 81(1):248-60. PubMed ID: 17035311
[TBL] [Abstract][Full Text] [Related]
10. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
11. Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.
Rechsteiner MP; Berger C; Weber M; Sigrist JA; Nadal D; Bernasconi M
J Gen Virol; 2007 May; 88(Pt 5):1454-1459. PubMed ID: 17412973
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus lytic cycle activation alters proteasome subunit expression in Burkitt's lymphoma cells.
De Leo A; Matusali G; Arena G; Di Renzo L; Mattia E
Biol Chem; 2010 Sep; 391(9):1041-6. PubMed ID: 20536393
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma.
Shirley CM; Chen J; Shamay M; Li H; Zahnow CA; Hayward SD; Ambinder RF
Blood; 2011 Jun; 117(23):6297-303. PubMed ID: 21447826
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds.
Matusali G; Arena G; De Leo A; Di Renzo L; Mattia E
Mol Cancer; 2009 Mar; 8():18. PubMed ID: 19272151
[TBL] [Abstract][Full Text] [Related]
15. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.
Anderton E; Yee J; Smith P; Crook T; White RE; Allday MJ
Oncogene; 2008 Jan; 27(4):421-33. PubMed ID: 17653091
[TBL] [Abstract][Full Text] [Related]
16. Dual regulation of hepatocyte apoptosis by reactive oxygen species: Increases in transcriptional expression and decreases in proteasomal degradation of BimEL.
Ishihara Y; Takeuchi K; Ito F; Shimamoto N
J Cell Physiol; 2011 Apr; 226(4):1007-16. PubMed ID: 20857401
[TBL] [Abstract][Full Text] [Related]
17. IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt's lymphoma cells.
Jordi M; Marty J; Mordasini V; Lünemann A; McComb S; Bernasconi M; Nadal D
PLoS One; 2017; 12(10):e0186614. PubMed ID: 29088270
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of proteolytic complexes following EBV activation in BL cells.
Matusali G; De Leo A; Gavioli R; Bertelli L; Di Renzo L; Mattia E
Biochem Biophys Res Commun; 2007 Jan; 352(4):947-52. PubMed ID: 17157806
[TBL] [Abstract][Full Text] [Related]
19. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
20. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata.
Komano J; Takada K
J Virol; 2001 Feb; 75(3):1561-4. PubMed ID: 11152530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]